Antibe Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
07 Mar 24 | BuyUS$7,427 | Daniel Legault | Individual | 20,000 | US$0.37 | |
07 Mar 24 | BuyUS$5,793 | Scott Curtis | Individual | 15,000 | US$0.39 | |
06 Mar 24 | BuyUS$9,600 | Joseph Stauffer | Individual | 24,000 | US$0.40 |
Insider Trading Volume
Insider Buying: ATBP.F insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 173,089 | 0.327% |
Institutions | 240,000 | 0.453% |
Individual Insiders | 2,695,659 | 5.09% |
General Public | 49,900,614 | 94.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,129,396 | US$243.5k | 1.8% | no data | |||
502,360 | US$108.3k | 0% | no data | |||
333,334 | US$71.9k | 4.17% | no data | |||
254,819 | US$55.0k | 33.3% | no data | |||
240,000 | US$51.8k | 0% | no data | |||
185,136 | US$39.9k | 7.76% | no data | |||
173,089 | US$37.3k | 69% | no data | |||
115,000 | US$24.8k | 15% | no data | |||
68,918 | US$14.9k | 0% | no data | |||
41,700 | US$9.0k | 4.16% | no data | |||
38,334 | US$8.3k | 43.8% | no data | |||
26,662 | US$5.7k | 0% | no data |